5-benzylsulfanyl-1,3,4-thiadiazol-2-amine

We are 5-benzylsulfanyl-1,3,4-thiadiazol-2-amine CAS:25660-71-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-benzylsulfanyl-1,3,4-thiadiazol-2-amine
CAS.NO:25660-71-3
Synonyms:5-(benzylsulfanyl)-1,3,4-thiadiazol-2-amine
5-benzylsulfanyl[1,3,4]thiadiazol-2-ylamine
2-benzylthio-5-amino-1,3,4-thiadiazole
2-amino-5-benzylthio-1,3,4-thiadiazole
5-(Benzylthio)-1,3,4-thiadiazol-2-amine
Molecular Formula:C9H9N3S2
Molecular Weight:223.31800
 
Physical and Chemical Properties:
Density:1.39
Melting point:152-155ºC
Boiling point:416.2ºC
Flash point:205.5ºC
Index of Refraction:1.693
 
Specification:
Appearance:Pale yellow solid
Purity:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:2-Benzylthio-5-amino-1,3,4-thiadiazole is used to study and investigate its antitumor activities against human cervix adenocarcinoma(HeLa), human liver cancer cell(SMMC-7721), human breast cancer cell(MCF-7) and human lung cancer cell(A549) lines that isfurther evaluated by CCK-8 assay.

5-benzylsulfanyl-1,3,4-thiadiazol-2-amine


Related News: Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.766-11-0 Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.isotiocianato de alilo CAS:57-06-7 China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.1,3-Dibromobenzene CAS:108-36-1 Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.

Related Products
Product Name
5-(3-Fluorophenyl)-2-methylpyridine View Details
Phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide View Details
2-bromo-1-(3,5-difluorophenyl)ethanone View Details
L-Norvaline manufacturer 2-Bromobutyric acid methyl ester manufacturer glutaric acid manufacturer 3-Amino-2-methylbenzoic acid manufacturer Atosiban Acetate manufacturer